GlassScriptPhysician profile
Nicholas A Kotch
NPI 1588942650
$37,228.51
in general payments reported to CMS, 2019-2025
35 companies · $6,340 in 2025
The $6,340 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,286 · 2021: $1,398 · 2022: $3,078 · 2023: $5,261 · 2024: $5,258 · 2025: $6,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $3,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,070.73 |
| Travel and Lodging | $3,788.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $13,538.16 | 2019-2025 | Acticor 7 Vr-T Dx, Solia, Amvia Edge |
| Medtronic Vascular, INC. | $6,128.86 | 2019-2020 | |
| Abbott Laboratories | $4,093.72 | 2019-2025 | Aveir, Perclose Prostyle, Ensite Precision |
| Biosense Webster, INC. | $3,071.68 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $2,625.61 | 2021-2025 | Micra, Affera Mapping System, Linq II |
| Boston Scientific Corporation | $2,184.05 | 2019-2025 | Farapulse, Rhythmia Mapping System, General - Therapies |
| Atricure, INC. | $1,327.99 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $925.21 | 2024-2025 | Optimizer |
| Cardiva Medical, INC. | $624.00 | 2019-2024 | Ensoetm, Cardiva Vascade Mvp Vvcs 6-12f |
| Vektor Medical INC. | $362.20 | 2025 | Vmap |
| Novartis Pharmaceuticals Corporation | $351.04 | 2021-2025 | |
| Heartflow, INC. | $286.43 | 2025 | |
| Philips North America LLC | $273.38 | 2023-2025 | Igt Devices Undivided, (Ck4) Mcot, Extended Holter |
| Acutus Medical, INC. | $271.16 | 2021-2023 | |
| Medical Device Business Services, INC. | $195.05 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $153.52 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.65 | 2019-2024 | Lifevest |
| Zoll Respicardia, INC. | $111.79 | 2024 | Remede System |
| Vital Connect, INC | $88.79 | 2023 | Vitalpatch Rtm |
| Shockwave Medical, INC | $80.45 | 2025 | |
| Janssen Pharmaceuticals, INC | $61.86 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.72 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $31.12 | 2025 | Eliquis, Camzyos |
| Elutia, INC. | $30.15 | 2023 | |
| Cleerly, INC. | $29.08 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Convatec INC. | $24.94 | 2025 | |
| Acumed LLC | $24.67 | 2025 | Ribloc, Biobridge |
| Lexicon Pharmaceuticals, INC. | $21.61 | 2024 | |
| Merck Sharp & Dohme LLC | $17.14 | 2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $16.84 | 2024 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $16.47 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $16.42 | 2024 | Nexletol |
| Volta Medical INC | $15.21 | 2024 | Vx1 |
| Amgen INC. | $15.03 | 2025 | Repatha |
| Cordis US Corp. | $14.51 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Kotch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.